Back to Browse Journals » International Journal of Nanomedicine » Volume 7
Degradation and osteogenic potential of a novel poly(lactic acid)/nano-sized β-tricalcium phosphate scaffold
Authors Cao L, Duan PG, Wang HR, Li XL, Yuan FL, Fan ZY, Li SM, Dong J
Received 14 September 2012
Accepted for publication 27 October 2012
Published 28 November 2012 Volume 2012:7 Pages 5881—5888
DOI https://doi.org/10.2147/IJN.S38127
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 5
Lu Cao,1,2 Ping-Guo Duan,1,2 Hui-Ren Wang,1,2 Xi-Lei Li,1,2 Feng-Lai Yuan,3 Zhong-Yong Fan,4 Su-Ming Li,5 Jian Dong1,2
1Department of Orthopedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China; 2State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China; 3Affiliated Third Hospital of Nantong University, Wuxi, Jiangsu, China; 4Department of Materials Science, Fudan University, Shanghai, China; 5Max Mousseron Institute on Biomolecules, Montpellier I University, Montpellier, France
Abstract: The purpose of this study was to investigate the influence of nano-sized β-tricalcium phosphate (β-TCP) on the biological performance of poly (lactic acid) (PLA) composite scaffolds by using in vitro degradation and an in vivo model of heterotopic bone formation. Nano-sized βTCP (nβ-TCP) was prepared with a wet grinding method from micro-sized β-TCP (mβ-TCP), and composite scaffolds containing 0, 10, 30, or 50 wt% nβ-TCP or 30 wt% mβ -TCP were generated using a freeze-drying method. Degradation was assessed by monitoring changes in microstructure, pH, weight, and compressive strength over a 26-week period of hydrolysis. Composite scaffolds were processed into blocks, and implanted into muscular pockets of rabbits after loading with recombinant human bone morphogenetic protein-2 (rhBMP-2). New bone formation was evaluated based on histological and immunohistochemical analysis 2, 4, and 8 weeks after implantation. The in vitro results indicated that the buffering effect of nβ-TCP was stronger than mβ-TCP, which was positively correlated with the content of nβ-TCP. The in vivo findings demonstrated that nβ-TCP enhanced the osteoconductivity of the scaffolds. Although composite scaffolds containing 30% nβ-TCP exhibited similar osteoconductivity to 50% nβ-TCP, they had better mechanical properties than the 50% nβ-TCP scaffolds. This study supports the potential application of a composite scaffold containing 30% nβ-TCP as a promising scaffold for bone regeneration.
Keywords: poly (lactic acid), β-tricalcium phosphate, biodegradation, porous scaffold, bone regeneration
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Other article by this author:
Biomechanical stability of a bioabsorbable self-retaining polylactic acid/nano-sized β-tricalcium phosphate cervical spine interbody fusion device in single-level anterior cervical discectomy and fusion sheep models
Cao L, Duan PG, Li XL, Yuan FL, Zhao MD, Che W, Wang HR, Dong J
International Journal of Nanomedicine 2012, 7:5875-5880
Published Date: 27 November 2012
Readers of this article also read:
Bone repair by periodontal ligament stem cell-seeded nanohydroxyapatite-chitosan scaffold
Ge S, Zhao N, Wang L, Yu M, Liu H, Song A, Huang J, Wang G, Yang P
International Journal of Nanomedicine 2012, 7:5405-5414
Published Date: 10 October 2012
Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity
Leite EA, Souza CM, Carvalho-Júnior AD, Coelho LG, Lana AM, Cassali GD, Oliveira MC
International Journal of Nanomedicine 2012, 7:5259-5269
Published Date: 9 October 2012
Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies
Monteiro LM, Lione VF, do Carmo FA, do Amaral LH, da Silva JH, Nasciutti LE, Rodrigues CR, Castro HC, de Sousa VP, Cabral LM
International Journal of Nanomedicine 2012, 7:5175-5182
Published Date: 28 September 2012
Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells
Zhou H, Yang L, Li H, Gong H, Cheng L, Zheng H, Zhang L, Lan Y
International Journal of Nanomedicine 2012, 7:4649-4660
Published Date: 22 August 2012
Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
Chen M, Le DQ, Hein S, Li P, Nygaard JV, Kassem M, Kjems J, Besenbacher F, Bünger C
International Journal of Nanomedicine 2012, 7:4285-4297
Published Date: 3 August 2012
Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2
Chen AZ, Wang GY, Wang SB, Li L, Liu YG, Zhao C
International Journal of Nanomedicine 2012, 7:3013-3022
Published Date: 18 June 2012
Nanofiber composites containing N-heterocyclic carbene complexes with antimicrobial activity
Elzatahry AA, Al-Enizi AM, Elsayed EA, Butorac RR, Al-Deyab SS, Wadaan MAM, Cowley AH
International Journal of Nanomedicine 2012, 7:2829-2832
Published Date: 7 June 2012
PLLA-PEG-TCH-labeled bioactive molecule nanofibers for tissue engineering
Chen J, Zhou B, Li Q, Ouyang J, Kong J, Zhong W, Xing MM
International Journal of Nanomedicine 2011, 6:2533-2542
Published Date: 21 October 2011
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Chen Y, Wan Y, Wang Y, Zhang H, Jiao Z
International Journal of Nanomedicine 2011, 6:2321-2326
Published Date: 18 October 2011
Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin
Ahangari Cohan R, Madadkar-Sobhani A, Khanahmad H, Roohvand F, Aghasadeghi MR, Hedayati MH, Barghi Z, Shafiee Ardestani M, Nouri Inanlou D, Norouzian D
International Journal of Nanomedicine 2011, 6:1217-1227
Published Date: 15 June 2011
